« New Report Recommends Enhanced Food Tracing Guidelines The Food and | Main | FDA To Look Into Safety of Caffeinated Alcoholic Beverages The »

FDA Approves Lysteda to Treat Heavy Menstrual Bleeding The U.S.


FDA Approves Lysteda to Treat Heavy Menstrual Bleeding
The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot.
 

©2006 FDA-News.com. All rights reserved.